Login
Related Links
Special News Items
- Gene therapy reduces stroke risk factors in sickle cell disease patients
- Second Patient Death After Gene Therapy: Implications For The Future
- A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma
- FDA approves Abeona’s epidermolysis bullosa gene therapy Zevaskyn
- New gene therapy drug approved for use in China
- Comprehensive AAV delivery map aids in advancing gene therapy
- Pfizer Drops Approved Hemophilia B Gene Therapy
- Hemophilia B Gene Therapy Achieves Sustained Benefit Over 4 Years
- NHS Approves Landmark Gene Therapy For Sickle Cell Disease
- Novartis’ investigational spinal muscular atrophy gene therapy shows promise in late-stage study
- India’s first gene therapy offers new hope for haemophilia patients
- Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
- A New Gene Therapy Technique Aims to Deliver Treatment Before Birth
- Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
- ISCT Becomes the First Cell and Gene Therapy Organization to Achieve ANAB Accreditation for Workforce Development
- First patient dosed in uniQure trial of AMT-191 gene therapy for Fabry
- Researchers say gene therapy breakthrough shows promise for glaucoma
- Switching Gene Therapy On and Off with a Pill
- Toddler Born Deaf Can Hear After Gene Therapy Trial Breakthrough Her Parents Call "Mind-Blowing"
- First Patient Begins Newly Approved Sickle Cell Gene Therapy
- FDA approves Orchard’s Lenmeldy gene therapy for MLD
- Team performs the first gene therapy tests in a whole human liver
- Gene Therapy Success in Hereditary Angioedema Patients
- FDA Approves CRISPR Gene Therapy to Treat Blood Disorder
- FDA Signals Imminent Approval for Sarepta’s Duchenne Gene Therapy: A Major Breakthrough for Patients
- Revolutionary gene therapy shows promise in treating autism
- Cell & Gene Therapy Space Gears Up for First CRISPR Approval
- Gene therapy restores hearing in children with rare form of deafness
- UK biotech AlveoGene launches with plans for inhaled gene therapy
- Gene Therapy Targets Chronic Pain